Filing Details
- Accession Number:
- 0001871002-24-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-03 17:48:16
- Reporting Period:
- 2024-05-01
- Accepted Time:
- 2024-05-03 17:48:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1871002 | Chad Gassert | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Svp - Corp. Dev. & Strategy | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-05-01 | 20,000 | $66.62 | 233,226 | No | 4 | S | Indirect | Held by Chali Properties LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Held by Chali Properties LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 49,679 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2023.
- The shares were sold in multiple trades at prices ranging from $66.05 to $67.30. The price reported above reflects the weighted average sales price.
- The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.